
Healthcare · NSE
Incorporated in May 2005, Onyx Biotec Limited is a pharmaceutical company focused on producing sterile water for injections and offering contract manufacturing services. It operates two facilities in Solan, Himachal Pradesh, where Unit I makes up to 6.38 lakh units of sterile water injections daily, and Unit II manufactures 40,000 units of dry powder injections and 26,667 units of dry syrup per day. The company caters to both domestic and international markets and serves over 100 clients, including well-known names like Hetero Healthcare, Mankind Pharma, Sun Pharma, and Reliance Life Sciences. Onyx Biotec is ISO 9001:2015 and ISO 14001:2015 certified and employed 175 people as of July 31, 2024.
Price Band
₹58 – ₹61
Issue Size
₹29.34 Cr
Lot Size
2000 shares
GMP
+8.2%
Est. Listing
₹66
at current GMP
Subscribed
198.68x
overall
Open
13 Nov 2024
Close
18 Nov 2024
Allotment
19 Nov 2024
Refund
20 Nov 2024
Demat Credit
21 Nov 2024
Listing
22 Nov 2024
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹61
Band: ₹58 – ₹61
Estimated Listing Price
₹66
Upper price + GMP
Lot Size
2000 shares
Min investment ₹1,22,000
Estimated Profit / Lot
₹10,000
2000 × ₹5
Grey Market Premium trend
+₹5
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹5 | 8.2% | ₹66 |
| 30 Oct 2026 | +₹5 | 8.2% | ₹66 |
| 29 Oct 2026 | +₹5 | 7.4% | ₹66 |
GMP is unofficial market data. Not a guarantee of listing performance.
Onyx Biotec Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹29.34 Crores. The shares are offered at a price band of ₹58 to ₹61 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2024-11-18, the basis of allotment is scheduled to be finalized on 2024-11-19. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Mas Services Limited) or the BSE allotment checking window.
The latest grey market premium for Onyx Biotec Limited IPO is ₹5, which indicates an expected listing price of ₹66.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.